Get started
Work

Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation

Year: 2025
Type: article
Study design: Observational Study
DOI: 10.1016/j.jtct.2025.09.048
Authors: Shannon R. McCurdy, Scott R. Solomon, Brian C. Shaffer, Meilun He, Yung-Tsi Bolon, Amanda G. Blouin, Alla Keyzner, Francisco A. Socola, Uroosa Ibrahim, Jun Zou, Hana Safah, Nakhle Saba, Shahinaz Gadalla, Miguel-Angel Perales, Sophie Paczesny, Steven G.E. Marsh, Effie W. Petersdorf, Tao Wang, Stephanie J. Lee, Ephraim J. Fuchs
Institutions: University of Pennsylvania, Northside Hospital, Memorial Sloan Kettering Cancer Center, National Marrow Donor Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Tulane University, The University of Texas MD Anderson Cancer Center, Louisiana State University, Franciscan Missionaries of Our Lady University, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Medical University of South Carolina, Anthony Nolan, The Royal Free Hospital, University College London, University of Washington, Fred Hutch Cancer Center, Medical College of Wisconsin, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
Funders: Health Resources and Services Administration, U.S. Public Health Service, National Institute on Aging, National Heart, Lung, and Blood Institute, Office of Naval Research, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Awards: Optimizing Allogeneic Hematopoietic Cell Transplantation for Older Patients with Hematologic Malignancies, G1790975258, G2026547544, G4047589214, Cancer Center Support Grant, A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research
OpenAlex ID: W4414806648
FWCI: 2.956
Cites: 30
Cited by: 4
Related to: 10